Michael Terrence Gibbs T2 Biosystems, Inc. (TTOO) insider trading activity

Michael Terrence Gibbs is General Counsel of T2 Biosystems, Inc.. Currently has a direct ownership of 135 shares of TTOO, which is worth approximately $303. The most recent transaction as insider was on Feb 24, 2024, when has been sold 29 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 135

0% 3M change

97.96% 12M change

Total Value Held $303

Michael Terrence Gibbs Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 24 2024	BUY Exercise of conversion of derivative security	-	29 Added 17.68%	135 Common Stock
Feb 20 2024	BUY Exercise of conversion of derivative security	-	40 Added 27.4%	106 Common Stock
Mar 28 2023	SELL Open market or private sale	$114 $0.48 p/Share	239 Reduced 3.49%	6,612 Common Stock
Mar 24 2023	BUY Exercise of conversion of derivative security	-	333 Added 4.64%	6,850 Common Stock
Feb 28 2023	SELL Open market or private sale	$935 $0.59 p/Share	1,585 Reduced 19.56%	6,517 Common Stock
Feb 24 2023	BUY Exercise of conversion of derivative security	-	2,914 Added 26.45%	8,102 Common Stock
Feb 22 2023	SELL Open market or private sale	$1,394 $0.65 p/Share	2,145 Reduced 29.25%	5,188 Common Stock
Feb 20 2023	BUY Exercise of conversion of derivative security	-	4,000 Added 35.3%	7,333 Common Stock
Apr 07 2022	BUY Open market or private purchase	$4,900 $0.49 p/Share	10,000 Added 5.66%	166,651 Common Stock
Mar 24 2022	SELL Payment of exercise price or tax liability	$3,868 $0.44 p/Share	8,790 Reduced 5.31%	156,651 Common Stock
Mar 24 2022	BUY Exercise of conversion of derivative security	-	16,666 Added 9.15%	165,441 Common Stock
Feb 24 2022	SELL Payment of exercise price or tax liability	$34,590 $0.45 p/Share	76,867 Reduced 35.65%	138,775 Common Stock
Feb 24 2022	BUY Exercise of conversion of derivative security	-	145,719 Added 40.33%	215,642 Common Stock
Feb 21 2022	SELL Payment of exercise price or tax liability	$2,479 $0.47 p/Share	5,275 Reduced 7.01%	69,923 Common Stock
Feb 21 2022	BUY Exercise of conversion of derivative security	-	10,000 Added 11.74%	75,198 Common Stock
Mar 25 2021	SELL Open market or private sale	$13,662 $1.56 p/Share	8,758 Reduced 10.68%	73,256 Common Stock
Mar 24 2021	BUY Exercise of conversion of derivative security	-	16,667 Added 16.89%	82,014 Common Stock
Feb 23 2021	SELL Open market or private sale	$14,997 $2.06 p/Share	7,280 Reduced 10.02%	65,347 Common Stock
Feb 21 2021	BUY Exercise of conversion of derivative security	-	10,000 Added 12.1%	72,627 Common Stock

MTG

Michael Terrence Gibbs

General Counsel

Lexington, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TTOO shares.

Notify only if

Value

Insider Trading

Get notified when an T2 Biosystems, Inc. insider buys or sells TTOO shares.

Notify only if

Operation

Value

Type

News

Receive news related to T2 Biosystems, Inc.

Track Activities on TTOO

Account